SELENOP and hepatocellular carcinoma: Furthermore, patients with HCC exhibit decreased SeP mRNA expression and reduced SeP protein levels in both tumor tissue and circulation [[30], [31], [32], [33]], which are significantly associated with higher tumor grade, reduced overall survival [32], and poor treatment response [33].